The Diagnosis and Treatment Pattern of CKD in Patients With Cardiovascular Disease- a National Cross-sectional Study
CREATIVE
1 other identifier
observational
2,000
1 country
1
Brief Summary
The goal of this observational study is to learn about in a total of approximately 2000 patients with cardiovascular disease recruited from about 25 participating sites in China with eGFR\<60 ml/min/1.73 m2 and/or UACR\>30 mg/g at least twice 3 months apart within the previous 12 months who had been hospitalized in the cardiology department within the previous 12 months. The main questions it aims to answer are:
- To estimate the diagnosis rate of CKD in patients with cardiovascular disease and laboratory evidence of CKD
- To describe the CKD awareness and treatment pattern in patients with cardiovascular disease and laboratory evidence of CKD.
- To describe the socio-demographic and clinical characteristics of CKD in patients with cardiovascular disease and laboratory evidence of CKD Participants will be invited to undergo a baseline visit, and the demographics, lifestyle factors, clinical characteristics, and laboratory tests will be collected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2023
CompletedFirst Submitted
Initial submission to the registry
August 20, 2023
CompletedFirst Posted
Study publicly available on registry
November 22, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2024
CompletedNovember 22, 2023
July 1, 2023
1 year
August 20, 2023
November 20, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
CKD diagnosis rates
CKD diagnosis rates in overall enrolled patients and subgroups (stratified by isolated estimated glomerular filtration rate (eGFR) measurement, isolated urinary albumin-to-creatinine ratio ( UACR) measurement, and both measurements) will be assessed in 12 month.
1 day
Secondary Outcomes (3)
Clinical characteristics
1 day
CKD diagnosis/treatment rate
1 day
The number, types, treatment rates of medicine
1 day
Eligibility Criteria
a total of approximately 2000 patients with cardiovascular disease recruited from about 25 participating sites in China
You may qualify if:
- Female and/or male aged ≥18 years
- Admitted to the cardiology department with diagnosed cardiovascular disease within the previous 12 months
- Participants with eGFR\<60 ml/min/1.73 m2 and/or UACR\>30 mg/g at least twice 3 months apart within the previous 12 months
You may not qualify if:
- Participants with known eGFR\<20 ml/min/1.73 m2 or undergoing dialysis or kidney transplantation
- Pregnant or lactating women
- Exposure to contrast medium or other reason leading to potential acute kidney injury since the baseline examination of eGFR/UACR
- Patients who were participating in or had participated in any other clinical trial within the previous 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Guangdong Provincial People's Hospital
Guangzhou, Guangdong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 20, 2023
First Posted
November 22, 2023
Study Start
July 1, 2023
Primary Completion
July 1, 2024
Study Completion
July 1, 2024
Last Updated
November 22, 2023
Record last verified: 2023-07